Advertisement | | The Vilcek Foundation congratulates the recipients of the 2016 Vilcek Prizes in Biomedical Science
Dan R. Littman (NYU School of Medicine) receives $100,000 Vilcek Prize Fernando Camargo (Boston Children's Hospital & Harvard University), Roberta Capp (University of Colorado School of Medicine), and Houra Merrikh (University of Washington School of Medicine) each win $50,000 Vilcek Prize for Creative Promise
Click here for more information | | | | |
TABLE OF CONTENTS | February 2016 Volume 22, Issue 2 | | | | | Editorial News News and Views Review Brief Communication Articles Letters Corrigenda Errata
| | | | | | Advertisement | | | | | Advertisement | | New! Nature Microbiology - First issue now published. The first issue of Nature Microbiology is now published and free to access online! This new journal covers all aspects of microorganisms, be it their evolution, physiology and cell biology; their interactions with each other, with a host or with an environment; or their societal significance. Ensure you stay up to date with future content by registering to receive the monthly e-alert. | | | | | Advertisement | | An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research.
Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation.
Now open for submissions | | | | | | Editorial | Top | | | | A windfall for US biomedical science p115 doi:10.1038/nm.4048 In December, the US government approved a $2 billion increase in the budget of the US National Institutes of Health (NIH) for the 2016 fiscal year. With that increase comes relief, optimism and the pressure to spend wisely.
| | | | News | Top | | | | News Feature | | | | An eye to the future: Researchers debate best path for stem cell-derived therapies pp116 - 119 Shraddha Chakradhar doi:10.1038/nm0216-116
| | | | News in Brief | | | | Biomedical briefing pp120 - 121 doi:10.1038/nm0216-120
| | | | News Feature | | | | Mutations as munitions: Neoantigen vaccines get a closer look as cancer treatment pp122 - 124 Alla Katsnelson doi:10.1038/nm0216-122
| | | | Advertisement | | An open access journal dedicated to highlighting the most important scientific advances in Parkinson's disease research, spanning the motor and non-motor disorders of Parkinson's disease.
Part of the Nature Partner Journals series, npj Parkinson's Disease is published in partnership with the Parkinson's Disease Foundation.
Open for submissions | | | | | | News & Views | Top | | | | Targeted stimulation of the spinal cord to restore locomotor activity pp125 - 126 Arthur Prochazka doi:10.1038/nm.4043 A new study has located 'hot spots' in the rat spinal cord that are associated with leg flexion and extension in rats. Electrical stimulation applied in an alternating pattern between these hot spots facilitated locomotion after the hindlimbs were paralyzed as a result of spinal cord injury (SCI).
See also: Article by Wenger et al. |
| | | | Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus pp126 - 127 Sylviane Muller and Marko Radic doi:10.1038/nm.4044 A new study of the pathogenesis of systemic lupus erythematosus (SLE) highlights the importance of mitochondria and mitochondrial reactive oxygen species (ROS) in the generation of neutrophil extracellular traps (NETs) that have the enhanced potential to elicit interferon-induced gene expression.
See also: Article by Lood et al. |
| | Review | Top | | | | Targeting EZH2 in cancer pp128 - 134 Kimberly H Kim and Charles W M Roberts doi:10.1038/nm.4036 Roberts and Kim discuss the mechanistic roles played by EZH2 in cancer as well as efforts to therapeutically target this epigenetic modifier.
| | Brief Communication | Top | | | | PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease pp135 - 137 Kuti Baruch, Aleksandra Deczkowska, Neta Rosenzweig, Afroditi Tsitsou-Kampeli, Alaa Mohammad Sharif et al. doi:10.1038/nm.4022 In Alzheimer's disease, PD-1 immune checkpoint blockade reduces pathology and improves memory in mice with established disease.
| | | Articles | Top | | | | | | | | | | | Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice pp163 - 174 Suzanne M Cloonan, Kimberly Glass, Maria E Laucho-Contreras, Abhiram R Bhashyam, Morgan Cervo et al. doi:10.1038/nm.4021 Reducing levels of mitochondrial iron by diet or pharmacological chelation ameliorates symptoms of cigarette smoke-induced chronic obstructive pulmonary disease in mice.
| | | | CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis pp175 - 182 Ting Zhang, Yan Zhang, Mingyao Cui, Li Jin, Yimei Wang et al. doi:10.1038/nm.4017 Myocardial injury induced by ischemia-reperfusion or doxorubicin leads to cardiomyocyte necroptosis via RIP3-mediated phosphorylation of CaMKII and opening of the mitochondrial permeability transition pore.
| | | | Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice pp183 - 193 Satoko Arai, Kento Kitada, Tomoko Yamazaki, Ryosuke Takai, Xizhong Zhang et al. doi:10.1038/nm.4012 A KIM-1-AIM interaction promotes clearance of cellular debris in renal tubules after acute kidney injury to improve disease outcome.
| | Letters | Top | | | | Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors pp194 - 201 Yi Du, Hirohito Yamaguchi, Yongkun Wei, Jennifer L Hsu, Hung-Ling Wang et al. doi:10.1038/nm.4032 c-Met binds to and phosphorylates PARP1 in cancer cells, thereby reducing PARP1 binding to a PARP inhibitor; c-Met and PARP inhibitor combination therapy shows improved efficacy in preclinical models of breast and lung cancer.
| | | | Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis pp202 - 209 Damian J Mole, Scott P Webster, Iain Uings, Xiaozhong Zheng, Margaret Binnie et al. doi:10.1038/nm.4020 Blocking the enzyme KMO with a small molecule reduces the levels of toxic tryptophan metabolites and reduces multiple extrapancreatic organ failure in a rat model of acute pancreatitis.
| | | | Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites pp210 - 216 Farokh Dotiwala, Sachin Mulik, Rafael B Polidoro, James A Ansara, Barbara A Burleigh et al. doi:10.1038/nm.4023 Judy Lieberman and colleagues show that intracellular parasites are eradicated by lymphocyte delivery of cytotoxic granule contents—perforin, granulysin and granzymes—into infected cells.
| | Corrigenda | Top | | | | Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis p217 Laura S Shankman, Delphine Gomez, Olga A Cherepanova, Morgan Salmon, Gabriel F Alencar et al. doi:10.1038/nm0216-217a
| | | | Corrigendum: Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats p217 Frank A Duca, Clemence D Cote, Brittany A Rasmussen, Melika Zadeh-Tahmasebi, Guy A Rutter et al. doi:10.1038/nm0216-217b
| | Errata | Top | | | | Erratum: Cardiac RKIP induces a beneficial [beta]-adrenoceptor-dependent positive inotropy p217 Evelyn Schmid, Stefan Neef, Christopher Berlin, Angela Tomasovic, Katrin Kahlert et al. doi:10.1038/nm0216-217c
| | | | Erratum: Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. p217 M Teresa Grande, Berta Sanchez-Laorden, Cristina Lopez-Blau, Cristina A De Frutos, Agnes Boutet et al. doi:10.1038/nm0216-217d
| | | | Erratum: Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma p217 Dany Nassar, Mathilde Latil, Bram Boeckx, Diether Lambrechts and Cedric Blanpain doi:10.1038/nm0216-217e
| | Top | | | Advertisement | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
| | | | | | You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount (You will need to log in to be recognised as a nature.com registrant) For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our customer feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
| |
|
| |
|
|
|
|
No comments:
Post a Comment